A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was whether videoassisted thoracic surgery (VATS) is the best treatment for paediatric pleural empyema. Altogether 274 papers were found using the reported search, of which 15 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that early VATS (or thoracotomy if VATS not possible) leads to shorter hospitalisation. The duration of chest tube placement and antibiotic use is variable and does not correlate with treatment method. Patients who underwent primary operative therapy had a lower aggregate in-hospital mortality rate (0% vs. 3.3%), re-intervention rate (2.5% vs. 23.5%), length of stay (10.8 days vs. 20.0 days), duration of tube thoracostomy (4.4 days vs. 10.6 days), and duration of antibiotic therapy (12.8 days vs. 21.3 days), compared with patients who underwent non-operative therapy. Similar complication rates were observed for the two groups (5% vs. 5.6%). Moreover, median hospital charges for VATS were $36,320 [interquartile range (IQR), $24,814-$62,269]. The median pharmacy and radiological imaging charges were $5884 (IQR, $3142-$11,357) and $2875 (IQR, $1703-$4950), respectively, for VATS and tube drainage. Adjusting for propensity score matching, costs for primary VATS were equivalent to primary chest tube placement. Only one article found discordant results. Ninety-five children (52%) received antibiotics alone, and 87 (45%) underwent drainage procedures (21 chest tube alone, 57 VATS/thoracotomy, and eight chest tube followed by VATS/ thoracotomy); only four received fibrinolytics. Mean (standard deviation) length of stay was significantly shorter in the antibiotics alone group, 7.0 (3.5) days vs. 11 (4.0) days. The strongest predictors of undergoing pleural drainage were admission to the intensive care unit and large effusion size ( > 1/2 thorax filled).
Introduction
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
Three-part question
In [children with empyema thoracis] is [video-assisted thoracoscopic surgery (VATS)] superior [to conservative management] in terms of [disease resolution, hospital stay, morbidity and mortality]?
Clinical scenario
You have been referred a five-year-old child with a large loculated pleural effusion. Blood tests and analysis of pleural fluid confirmed the presence of an empyema. He was treated conservatively for four weeks by the district hospital paediatricians without success. You wonder if an earlier referral for thoracoscopic surgery, considering its lower morbidity, would have been more appropriate to improve the resolution of the empyema. You resolve to check the literature yourself.
Search strategy
Medline 1948 to January 2011 using OVID interface (exp Empyema/OR empyema.mp) AND (exp Child/OR exp Pediatrics/OR exp Infant/ OR pediatric.mp OR paediatric.mp) AND (exp Thoracic Surgery/OR Thoracoscop$.mp OR VATS.mp OR Thoracotomy.mp)
Search outcome
Two hundred and seventy-four papers were found using the reported search. From these, 15 papers were identified that provided the best evidence to answer the question. These are presented in Table 1 .
In addition, the reference list of each paper was searched. ) following another pneumothorax one, readmission occurring more frequently procedure two, reintubation one, in older patients and those treatment failure seven, with a lower admission death two) hematocrit. Early VATD decreased the length of LOS (days) Mean LOS 10.1 days, but was hospitalisation significantly longer if VATS followed another procedure or if a complication occurred. The risk for complications correlated with older age (6.2 years vs. 8.8 years, P = 0.023) and lower hematocrit on admission (31.1% vs. 27.9%, P = 0.006) CI, confidence interval; IQR, interquartile range; LOS, length of hospital stay; S.D., standard deviation; VATD, video-assisted thoracoscopic decortication; VATS, video-assisted thoracic surgery; ICU, intensive care unit.
Results
Firstly, we must acknowledge that the treatment of pleural empyema in children differs considerably from that in adults due to the superior healing potential of paediatric patients. Empyema in children usually develops as a complication in 0.6% of bacterial pneumonias. Parapneumonic effusions have been described to encompass three stages progressing from sterile effusion, fibrin deposition leading to formation of a thick cortex with lung entrapment. Mahant et al. [2] reviewed three randomised controlled trials [3] [4] [5] comparing VATS with chest drain and fibrinolytics. Sonnappa et al. [3] and St. Peter et al. [4] used small (8-12-F) chest drains, and fibrinolytics were administered as a standing order. Kurt et al. [5] , however, used larger chest drains (16-24-F) and administered fibrinolytics as a rescue therapy based on imaging and drainage. The study by Kurt et al. [5] was stopped early owing to an observed benefit in mean hospital stay (5.8 ± 2.8 days vs. 13.2 ± 7.2 days, P < 0.01) with VATS compared to chest drain with fibrinolytics. Hospital stays were equivalent between VATS and chest drain with fibrinolytics in two other studies In contrast, Shah et al. [6] found that median hospital charges for VATS were $36,320 [interquartile range (IQR), $24,814-$62,269]. The median pharmacy and radiological imaging charges were $5884 (IQR, $3142-$11,357) and $2875 (IQR, $1703-$4950), respectively, for VATS and tube drainage. Adjusting for propensity score matching, costs for primary VATS were equivalent to primary chest tube placement. This is, in contrast, to a meta-analysis of 67 studies conducted by Avansino et al. [7] who compared children initially treated non-operatively (3418 cases from 54 studies) to children treated with a primary operative approach (363 cases from 25 studies). Patients who underwent primary operative therapy had lower in-patient mortality rate (0% vs. 3.3%), re-intervention rate (2.5% vs. 23.5%), hospital stay (10.8 days vs. 20.0 days), duration of tube thoracostomy (4.4 days vs. 10.6 days) and duration of antibiotic therapy (12.8 days vs. 21.3 days), compared with patients who underwent non-operative therapy. Similar complication rates were observed for the two groups (5% vs. 5.6%).
Li and Gates [8] analysed 1173 patients from a national hospital database and found that children who had primary operative management were less likely to have therapeutic failure compared with children with non-operative management (NM) ( Shah et al. [9] analysed 961 patients that had complicated pneumonia and underwent early pleural fluid drainage. Initial procedures included chest tube placement (n = 714), VATS (n = 50), and thoracotomy (n = 197). In linear regression analysis, children undergoing primary VATS had a 24% (adjusted coefficient, -0.24; 95% CI, -0.41 to -0.07) shorter hospital stay than those undergoing primary chest tube placement, which translates into a 2.8-day shorter stay. In logistic regression analysis, patients undergoing primary VATS had an 84% (adjusted OR, 0.16; 95% CI, 0.06-0.42) reduced requirement for additional pleural fluid drainage procedures compared with patients undergoing primary chest tube placement.
Gates et al. [10] reviewed 44 retrospective studies involving 1369 patients. Four treatment strategies were compared: chest tube drainage alone (16 studies, 611 patients), chest tube drainage with fibrinolytic instillation (10 studies, 83 patients), thoracotomy (13 studies, 226 patients), and video-assisted thoracoscopic decortication (VATD; 22 studies, 449 patients). Patients undergoing early VATS or thoracotomy had shorter hospital stay (P = 0.003). There was a trend for shorter duration of postoperative fever compared with chest tube alone or with fibrinolytic therapy (P = 0.055). There was no statistical difference in chest tube duration between methods. There was no trend correlating antibiotic use with treatment methods, length of hospital stay, duration of fever, or length of chest tube requirement.
Bishay et al. [11] analysed 114 children who underwent VATS for empyema and reported median pleural cavity drainage time of four (2-13) days. Median postoperative hospital stay was seven (4-36) days. There were seven complications (6%): air leak (n = 6) and lung injury (n = 1). One hundred and four (91%) children had full resolution of symptoms. There were eight (7%) treatment failures: five conversions to thoracotomy and three recurrent empyemas. This contrasts with Sonnappa et al. [3] who reported a failure rate for VATS of 16.6%.
Similarly, Cohen et al. [12] found that patients undergoing thoracoscopic drainage and decortication also had significantly shorter durations of intravenous antibiotic therapy (7.6 ± 1.2 days vs. 18.2 ± 7.5 days), chest tube drainage (4.0 ± 0.5 days vs. 10.2 ± 6.1 days), and hospital stay (7.4 ± 0.8 days vs. 15.4 ± 7.4 days).
In contrast, Carter et al. [13] reviewed 182 children who received antibiotics alone (n = 95) or underwent drainage procedures (n = 87) (21 chest tube alone, 57 VATS/thoracotomy, and eight chest tube followed by VATS/thoracotomy) and reported shorter mean ± standard deviation hospital stay in the antibiotics alone group (7.0 ± 3.5 days vs. 11 ± 4.0 days). Intensive care unit admission and large effusion size (> 1/2 thorax filled) are strong predictors for pleural drainage requirement.
Similar finding in children with parapneumonic empyemas were reported by another four studies [14] [15] [16] .
Clinical bottom line
On the basis of the reported studies, we conclude that early VATS (or thoracotomy if VATS is not possible) leads to shorter hospitalisation. The duration of chest tube placement and antibiotic use is variable and does not correlate with treatment method. 
